Human papillomavirus vaccine (Novavax)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman papillomavirus vaccine (Novavax)
Drug Alias Name人乳头瘤病毒疫苗-NovavaxHPV-16 vaccine - King/NovavaxHPV-16 L1 VLP vaccine - NovavaxHPV-16 L1 vaccine - King/NovavaxCervical cancer vaccine - King/Novavax +[7] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer InstituteNovavax
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovavaxNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A